SummaryThe effect of STZ-induced diabetes of 8-weeks duration was examined on nitric oxide-mediated neurotransmission in the rat anococcygeus muscle. In the presence of noradrenergic blockade and raised tissue tone, relaxant responses to nerve stimulation (0.5-5 Hz, for 10 s), sodium nitroprusside (5 and 10 nmol/1) and nitric oxide (1 and 3 gmol/l) were significantly reduced in anococcygeus muscles from diabetic rats compared to responses from control rats (p < 0.05). In contrast, relaxations to papaverine (3 and 10 gmol/1) were not reduced in tissues from diabetic rats. The nitric oxide synthesis inhibitor NOLA (100 gmol/1) abolished relaxant responses to nerve stimulation but had no effect on responses to any of the relaxant agents used. Exposure to NOLA at 10gmol/1 reduced stimulation-induced relaxations; this reduction was significantly greater in tissues from the diabetic group than from the control group (p < 0.05), probably as a consequence of the smaller relaxant responses in muscles from diabetic rats. Contractile responses to nerve stimulation (1-10 Hz, for 10 s), but not noradrenaline (0.03-30 gmol/1), were significantly greater in anococcygeus muscles from diabetic rats than from control rats (p < 0.05). NOLA (100gmol/1) significantly enhanced stimulation-induced contractions (p < 0.05), however the enhancement was significantly less in tissues from diabetic rats (p<0.05). The results suggest that STZ-induced diabetes impairs smooth muscle reactivity to nitric oxide in the rat anococcygeus muscle. [Diabetologia (1994) 37: 232-237] Key words Anococcygeus muscle (rat), diabetes, nitrergic nerves, nitric oxide, NOLA, NANC transmission, nonvascular smooth muscle, sodium nitroprusside, streptozotocin.Neuropathy of the autonomic nervous system is a complication of diabetes mellitus which may contribute to alterations in cardiovascular, gastrointestinal and genitourinary function [1,2]. These alterations may be manifested through clinical problems including postural hypotension, diabetic diarrhoea, diabetic cystopathy and impotence. The STZ-treated rat, an estab- lished animal model of insulin-dependent diabetes mellitus, has been extensively used to study the occurrence of diabetic autonomic neuropathy. Neurochemical and histochemical techniques have revealed that changes occur in the intestinal myenteric innervation of STZ-induced diabetic rats, including degeneration of noradrenergic nerves, reduced transmitter levels in serotonergic nerves, and increased choline acetyl transferase activity in cholinergic nerves [3][4][5][6]. In addition, functional studies have demonstrated that abnormalities occur in cholinergic neuromuscular transmission in rat small intestine [7,8], and in myogenic reactivity to neurotransmitters and autacoids in rat jejunum [9], bladder [10], vas deferens [11] and various vascular preparations [12].The NANC inhibitory innervation of gastrointestinal tissue from STZ-treated rats has been investigated, with specific alterations to the purinergic [13] and pep-